Skip to main content
. 2022 Feb 28;9:20543581221081207. doi: 10.1177/20543581221081207

Figure 5.

Figure 5.

Medication usage at initial and last clinic visits.

Note. RAASi = renin-angiotensin-aldosterone system inhibitor; SGLT2i = sodium-glucose cotransporter-2 inhibitor; GLP-1RA = glucagon-like peptide-1 receptor agonist.